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Abstract 
Here we test whether tl~e incorporation of docosahexaenoic acid (DHA, 22:6), an (n - 3) fatty acid, into lymphocyte membranes 
affects the expression of the surface proteins Thy-l.2 and CD8. DHA was incorporated into splenocytes by three methods: feeding mice 
diets containing menhaden (fish) oil, fusing splenocytes with DHA-containing phosphatidylcholine vesicles, and culturing splenocytes 
with DHA. Thy-l.2 and CD8 expression were measured by flow cytometry and complement-mediated lysis using a panel of monoclonal 
antibodies. As (n - 3) fatty acid incorporation i to the lymphocytes increased, the expression of one Thy-l.2 epitope and one CD8 
epitope decreased; the expression of two CD8 epitopes increased. Although diet-induced changes in surface protein expression may result 
from selective migration of cell populations or the diet's effect on protein biosynthesis, fusion with lipid vesicles demonstrated that 
DHA-containing phospholipids can mediate a direct and immediate ffect. The decrease in Thy-l.2 expression was sustained for more 
than a week after removal of (n - 3) fatty acids from the diet, most likely due to retention of membrane-bound (n - 3) fatty acids. 
Because Thy-l.2 and CD8 participate in T cell activation, modulation of their expression by DHA suggests that DHA, when serving as a 
membrane structural element, may alter immune function. 
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1. Introduction 
There is a growing interest in polyunsaturated fatty 
acids of the (n - 3) series, fatty acids in which the last 
double bond is three carbons from the methyl or omega 
end of the acyl chain. The (n - 3) fatty acid docosahex- 
aenoic acid (DHA, 22:6) is the most unsaturated fatty acid 
found in any biological system, containing twenty two 
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carbons and six unsaturations at positions 4, 7, 10, 13, 16 
and 19. DHA is usually found in large amounts in brain, 
rod outer segment, and sperm [1], where it presumably 
serves a specific purpose; however, DHA may be in- 
creased in other tissues through diet. 
Long chain (n - 3) fatty acids are abundant in fish oil, 
and associated with health benefits for neurologic develop- 
ment, cardiovascular disease, cancer, and arthritis. By 
influencing immunologic processes, fish oil-rich diets pro- 
tect against autoimmune disease in strains of mice prone to 
systemic lupus erythematosus, and they lower susceptibil- 
ity to rheumatoid arthritis in normal mice [2-4]. In part, 
(n - 3) fatty acids act by altering production of eicosanoid 
hormones (prostaglandins and leukotrienes) [5,6], thereby 
reducing inflammation. Leukotrienes may modulate T cell 
populations by inhibiting CD4 ÷ but enhancing CD8 ÷ T 
cell proliferation [6], and thus, not unexpectedly, dietary 
(n - 3) fatty acids are associated with increased CD8 ÷ [7] 
but not CD4 ÷ [8] T cell populations. 
In addition to altering eicosanoid hormone production, 
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(n -  3) fatty acids play a structural role in biological 
membranes. Enrichment of membranes with DHA alters 
fluorescence of the membrane probe MC540 [9] and in- 
creases membrane permeability [10], structural alterations 
consistent with the induction of discreet membrane do- 
mains. If DHA-rich membrane domains form, then mem- 
brane proteins may segregate to some extent into domains 
having the preferred lipid environment. Protein function is 
known to be affected by the lipid environment [1]. The 
specific question yet to be answered is the following: if 
DHA alters lymphocyte plasma membrane structure and 
affects surface proteins, will DHA then modulate immune 
responses through a structural as well as a hormonal 
mechanism? 
One lymphocyte membrane protein that is a candidate 
for modulation by DHA is Thy-l, a glycosylphosphatidyli- 
nositol (GPI)-linked glycoprotein present primarily on 
murine T cells but also expressed on neuronal cells, non- 
neuronal accessory cells, fibroblasts and dendritic epider- 
mal cells [11]. Thy-1 exists as two allelic forms, Thy-l.1 
and Thy-l.2, that differ by the single amino acid at 
position 89 [12]. It is used as a marker for T cells, but its 
specific function remains unclear [12]; it may play a role 
during development, cell recognition, signal transduction, 
and in the proliferation pathways of certain cell types [13]. 
CD8, on the other hand, is a heterodimeric membrane 
protein whose subunits each have a single transmembrane 
domain [14]. CD8 is present on a subset of T cells, binds 
to a monomorphic portion of MHC I, and is associated 
with a protein tyrosine kinase acting during T cell activa- 
tion [15]. It is not known whether the presence of DHA in 
the plasma membrane of T cells changes the expression of 
proteins such as Thy-I and CD8, which are involved in 
cell activation, and in turn alters immune responses. Here 
we monitor the expression of Thy-l.2 and CD8 as a 
function of DHA incorporation into splenocytes through 
diet, liposome fusion, and cell culture. 
Table 1 
Fat composition fexperimental diets 
Oil % (w/w); diet designation 
1 2 3 4 5 6 
Corn 10.5 0.5 0.5 0.5 0.5 0.5 
Hydrogenated coconut 0 10 7.5 5 2.5 0 
Menhaden 0 0 2.5 5 7.5 10 
libitum and fresh food (approximately twice their usual 
daily consumption) at the beginning of the dark cycle (7 
pm-7 am). Uneaten food was removed at the beginning at 
the light cycle. Mice were maintained on the diets for 3 
weeks or the amount of time indicated. There was no 
significant difference between diets in mouse weight gain 
or the amount of food eaten. Mice that were not on 
experimental diets (adult BALB/c  and ICR males, both 
strains from Harlan Sprague Dawley) received Purina ro- 
dent feed #5001 and tap water ad libitum. Mice were 
killed under the guidelines of the Panel on Euthanasia of 
the American Veterinary Medical Association. There were 
three to five mice per experimental diet group. 
2.2. F low cytometry 
Splenocytes were washed with phosphate buffered saline 
containing 0.1% sodium azide and 0.2% bovine serum 
albumin (PBS-NaN3-BSA), and incubated in 100 #I of 
PBS-NaN3-BSA plus 1 /xg of phycoerythrin-conjugated 
anti-Thy-l.2 antibody (clone 30-H12, Boehringer-Man- 
nheim, Indianapolis, IN) for 30 rain on ice. The cells were 
then washed with PBS-NaN3-BSA, and red blood cells 
were lysed by osmotic shock. Cell viability was deter- 
mined with propidium iodide (Boehringer Mannheim, Indi- 
anapolis, IN). Fluorescence was measured on an Epics 
Profile II flow cytometer (Coulter, Hialeah, FL). The 
2. Mater ia l s  and  methods  
2.1. Mice and diets 
Weanling BALB/c  male mice (Harlan Sprague Daw- 
ley, Indianapolis, IN) were fed modified AIN-76 pelleted 
diets (ICN Nutritional Biochemicals, Cleveland, OH) that 
contained 20% casein, 0.3% DL-methionine, 15% corn- 
starch, 5% alphacel, 0.2% choline bitartrate, 3.5% AIN-76 
mineral mixture, 1% AIN-76 vitamin mixture, 44.5% su- 
crose and 0.5% corn oil (CO) plus an additional 10% oil as 
CO, hydrogenated coconut oil (HCO), or menhaden oil 
(MO, a generous gift from Zapata Haynie Corporation, 
Reedville, VA). The six diets are outlined in Table 1. 
Table 2 shows the fatty acid composition of Diet 1 (10% 
corn oil), Diet 2 (10% hydrogenated coconut oil), and Diet 
6 (10% menhaden oil). The mice received tap water ad 
Table 2 
Fatty acid composition fdiets 1, 2, and 6 a 
Fatty acid % of total fatty acids 
corn oil hydrogenated coconut oil menhaden oil 
diet 1 diet 2 diet 6 
14:0 0.1 22.6 7.8 
14:1 0.0 1.3 0.0 
16:0 13.2 19.1 14.0 
16:1 0.0 0.0 10.0 
18:0 2.3 17.0 1.8 
18:l(n -9) 31.0 10.0 13.7 
18:2(n -6) 51.7 21.0 6.8 
18:3(n -3) 1.1 0.3 3.3 
20:1 0.1 0.0 1.2 
20:2 0.0 1.3 0.1 
20:4(n - 6) 0.0 0.0 0.5 
20:5(n - 3) 0.0 0.0 13.4 
22:5(n -3) 0.0 0.1 1.7 
22:6(n - 3) 0.0 0.0 9.7 
a Fatty acids found at less than 0.5% are not shown. 
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lymphocyte population was gated using forward scatter 
and side scatter, and a phycoerythrin-conjugated rat anti- 
DNP antibody was used as a negative control. Each cell 
population was stained in triplicate and all samples were 
run once each. 
2.3. Flow cytometry data analysis 
Histograms were compared by linear regression analysis 
with the program Regress ® (Boehringer-Mannheim, Indi- 
anapolis, IN) [16]. Fluorescence values for each channel of 
two histograms were treal:ed as paired data (x, y); identical 
histograms produce a straight diagonal line. Residuals 
(difference between the observed values versus values 
expected for identical his~:ograms) were calculated for each 
point, and the mean residaal was expressed as a percentage 
of the peak height of one histogram. This value, the 
regression index (RI), is positively related to the disparity 
between histograms, and zero for identical histograms. 
2.4. Preparation of 51Cr-labeled Con A blasts 
Splenocytes from two mice were cultured in 60 mm 
tissue culture dishes at 5.106 cells/ml of RPMI 1640 
plus antibiotics, 25 mM Hepes buffer, 2 mM glutamine, 50 
/zM 2-mercaptoethanol, 5% fetal bovine serum (FBS), and 
2.5 /zg of concanavalin A (Con A, Pharmacia Biotech, 
Piscataway, NJ) per ml (5-7 ml/dish). After 2 days in a 
humidified 37 ° C atmosphere with 5% CO 2, the cells were 
harvested, washed in PBS, and labeled for 1 h in 100-150 
/.tCi sodium [SICr]chromate (New England Nuclear- 
Dupont, Boston, MA) in < 1 ml of RPMI plus 5% FBS. 
Washed, labeled blasts v~ere suspended at l • 105 cells/ml 
of RPMI plus 20% FBS (either heat inactivated or un- 
treated). 
2.5. Preparation of fatty acid-supplemented medium 
Our method is based on that of Spector and Hoak [17]. 
Briefly, 5 mg of free fatty acid, 22 :6(n -3)  (NuChek, 
Elysian, MN), was dissolved in 5 ml of hexane, and then 
added to a thin layer of Celite powder (1 /xmol fatty 
acid/1 g Celite; Sigma3. After evaporating the hexane 
under nitrogen, the fatty acid-Celite mixture was added to 
100 ml of 1% (w/v)  BSA in RPMI 1640 (supplemented 
with antibiotics, 25 mM Hepes buffer, and 2 mM glu- 
tamine). The suspension was stirred for 30 min at room 
temperature in the dark, and the supernatant was recovered 
by centrifugation at 11 000 × gmax for 10 min at 4 °C, 
followed by filtration through a 0.22 /x Millipore dispos- 
able filter unit. Control medium was prepared similarly, 
but without he addition of free fatty acid. The media were 
stored frozen until used, at which time they were supple- 
mented with FBS and 2-mercaptoethanol. A preliminary 
experiment in which 5 mg of 22:6 was spiked with 0.5 
/xCi (1.5 ng) of [3H]20:4 indicated that more than 50% of 
the fatty acid (i.e., 25 /xg/ml) eluted into the BSA solu- 
tion (Stone, J. and Jenski, L., unpublished observation). 
2.6. Cell lysis with antibody and complement 
5~ Cr-labeled splenic Con A blasts were distributed into 
replicate wells (1 - 10  4 cells in 100 /xl/well) of microtiter 
plates to which 100 /xl of monoclonal antibody had been 
added; in each assay, four dilutions of each antibody were 
tested. Monoclonal anti-Thy-1 clone 30-H12 (rat IgG2b, 
FITC-conjugated) was obtained from Becton Dickinson 
(Mountain View, CA). The anti-CD8 antibodies were con- 
ditioned media from cell lines HO-2.2 (anti-Lyt-2.2, mouse 
IgM) [18], 3.155 (anti-Lyt-2, rat IgM) [19], and 2.43 
(anti-Lyt-2.2, rat IgG2b) [19] purchased from the Ameri- 
can Type Culture Collection (ATCC, Rockville, MD). The 
plates were incubated for 30 min at 4 ° C, washed three 
times in PBS plus 20% FBS, and then incubated for 30 to 
60 min at 37°C with complement (Low Tox M rabbit 
complement, Cedarlane, Hornby, Ontario, Canada), diluted 
1:20 to 1:40. Wells that lacked antibody received either 
complement (background), medium only (spontaneous re- 
lease), or detergent (maximum release). After centrifuga- 
tion (400 X g, 5 rain), 100 /xl was removed from each 
well, and radioactivity present in the supernatant was 
measured in a Beckman Gamma 5500 gamma counter 
(Fullerton, CA). Percent specific lysis was calculated as 
((experimental cpm-  background cpm)/(maximum cpm 
-background cpm))X 100. Significant differences (P < 
0.05) were determined by an independent S udent's t-test 
with the program WinStar (Anderson Bell, Arvada, CO). 
2.7. Lipid vesicle-cell fusions 
The phospholipids 1-stearoyl,2-oleoylphosphatidylcho- 
line (18:0,18:1 PC) and 1-stearoyl,2-docosahexaenoylphos- 
phatidylcholine (18:0,22:6 PC) (Avanti Polar Lipids, Al- 
abaster, AL) were dissolved in chloroform and dried under 
a stream of nitrogen followed by overnight vacuum. Lipids 
were hydrated in PBS and sonicated on ice for 5 min with 
a Heat Systems W-380 cell disrupter at setting 5 to pro- 
duce small unilamellar vesicles. Lipid vesicle suspensions 
(0.125 to 1.0 mg/ml of PBS) were mixed with splenocytes 
(108 cells/ml vesicle suspension) at room temperature for 
1 h in the dark. The cells were then washed once with cold 
PBS + 10% BSA, and three times with PBS + 10% FBS. 
In some experiments, 18:0,22:6 PC was spiked with the 
fluorescent lipid N-(lissamine rhodamine B sulfo- 
nyl)diacylphosphatidylethanolamine (Avanti Polar Lipids, 
Alabaster, AL) at a molar ratio of 300:1 to monitor the 
efficiency of lipid fusion by fluorimetry (MPF-66, Perkin- 
Elmer, Norwalk, CT). 
2.8. Gas chromatography 
Cells were extracted with CHC13/CH3OH (2:1, v/v),  
and the lipid extracts were rotovaporated to a small vol- 
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ume. Lipids were saponified in 0.5 M methanolic NaOH 
by refluxing for 1 h. Fatty acids were esterified by the 
addition of BF3-methanol and refluxing again for an addi- 
tional 30 to 45 min. Methyl esters were extracted in 
hexane and rotovaporated to a small volume. Two gas 
chromatography s stems were used: 2 /xl of the methyl 
esters were analyzed on a SRI Gas Chromatograph (Tor- 
rance, CA) equipped with a flame ionization detector and a 
packed column of 10% SP-2330 on 100/120 Chromosorb 
WAW. The oven temperature increased from 190°C to 
225 ° C over 25 min during the course of the run. Alterna- 
tively, 1 /zl of the fatty acid methyl esters was injected 
into a Shimadzu GC-17A gas chromatograph equipped 
with a Stabilwax capillary column (0.25 mm × 30 m; 
Restek, Bellefonte, PA), and the following temperature 
ramp was used: 180°C for 1 min, increased at 5°C per 
min to 245 ° C, held at 245°C for 10 min. Identification of 
the peaks was performed by direct comparison to the 
retention times of methyl ester standards (NuCheck, 
Elysian, MN). 
AMOUNT OF 18:0,22:6 PC IN LIPID SUSPENSION (mg/ml) 
Fig. 1. Estimation of lipid vesicle fusion with lymphocytes. A trace 
amount of fluorescent phosphatidylethanolamine was added to 18:0,22:6 
PC, which was fused at various concentrations with splenic blasts. The 
amount of 18:0,22:6 PC incorporated into cells was estimated from 
cell-associated fluorescence; the standard curve from which this informa- 
tion was derived is shown in the inset. The 'zero' lipid control acked the 
fluorescent tracer. 
3. Results 
3.1. Effect of DHA on Thy-I expression 
Both our own work [20,21] and that of others [8,22-24] 
suggest hat changes in membrane fatty acid composition 
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may affect surface proteins. Thus, we predicted that the 
presence of DHA in the splenocyte membrane may alter 
the apparent expression of T cell surface molecules. To 
test the direct effect of a DHA-containing phospholipid on 
Thy-1 expression, we fused 18:0,22:6 PC lipid vesicles 
with splenic Con A blasts in vitro. In some experiments, 
fusion was monitored with a fluorescent phospholipid in- 
cluded in the 18:0,22:6 PC vesicles. As shown in Fig. 1, 
the amount of fluorescent lipid incorporated into cells was 
proportional to the concentration of the lipid suspension 
used in the fusion, and the amount of 18:0,22:6 PC 
associated with the cells could be estimated from the 
fluorescence intensity standard curve. We demonstrated 
previously that efficiency of fusion correlated with the 
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70 
type of carrier lipid [21], indicating that the fluorescent 
probe was not entering the cells independently of the 
carrier phospholipid. 
To measure Thy-1 expression, we used anti-Thy-l.2 in 
a complement-mediated lysis assay. In this assay, cell lysis 
(51Cr release) is dependent upon the binding of antibodies 
to cell surface molecules (e.g., Thy-1) followed by the 
activation of complement to the terminal, pore-forming 
stage. Fig. 2A demonstrates that fusion of 18:0,22:6 PC 
with Con A-stimulated spleen cell blasts reduced Thy-1 
expression (measured by complement-mediated lysis) in a 
dose-dependent fashion. Fusion with 18:0,22:6 PC modu- 
lated Thy-I expression more dramatically than 18:0,18:1 
PC (Fig. 2B); the phospholipid concentrations of the vesi- 
cle suspensions were adjusted to achieve quimolar phos- 
pholipid incorporation. We previously reported the behav- 
ior of 18:0,18:1 PC to be intermediate between 18:0,22:6 
PC and sham treatments in a similar system [21]. Thy-I 
expression was monitored in a total of four fusion experi- 
ments. 
In these experiments we have introduced DHA into the 
plasma membrane in PC molecules. PC is the predominant 
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Table 3 
Thy-l expression on splenocytes timulated with Con A in culture 
medium supplemented with DHA 
Medium supplement % Specific lysis ~ (percent of control) 
experiment 1 experiment 2 
None 57.1 + 4.4 67.6 + 0.7 
22:6(n -3 )  48.8 + 2.0 ~ 59.1 _+4.1 b 
(85%) (87%) 
a Means+_ S.D. (n = 3). 
b Significantly different from control (no fatty acid supplement), P < 0.05, 
Student's t-test, 
phospholipid in the outer leaflet of most biological mem- 
branes, and DHA can be found in PC. However, lympho- 
cytes may not naturally produce a plasma membrane with 
DHA exclusively in PC at these levels. Therefore, we 
tested whether splenocytes, after incorporating DHA into 
membrane phospholipids via their own metabolic path- 
ways, also showed decreased Thy-1 expression. We cul- 
tured splenocytes with medium containing albumin-bound 
DHA (and Con A) for 48 h. Relative Thy- 1 expression was 
then quantified by a 51Cr release assay with anti-Thy-l.2 
and complement. The two independent experiments per- 
formed are shown in Table 3. In each case, there is a 
significant, albeit small decrease in Thy-1 expression on 
splenocytes cultured with DHA compared to control 
medium (P < 0.05, Student's t-test). Fatty acid was incor- 
porated from the medium into the cells, causing the per- 
cent of DHA among total fatty acids to increase more than 
three fold (Table 4). Thus, it is likely that DHA is entering 
triacylglycerol as well as phospholipid pools, and internal 
as well as plasma membranes. However, whether intro- 
duced as a preformed phospholipid or free fatty acid, DHA 
is associated with reduced expression of this Thy-1 epi- 
tope. 
In biological system,;, DHA is efficiently incorporated 
from the diet into cellular membranes. Hence, we pre- 
dicted that Thy-1 expression on splenocytes would de- 
Table 4 
Gas chromatography of splenocytes stimulated with Con A in culture 
medium supplemented with DHA 
Fatty acid a ~ of total fatty acids; 
fatty acid supplement in medium 
control 22:6 
14:0 2.2 2.9 
16:0 34.0 36.2 
16: l 6.0 0.8 
18:0 16.6 15.3 
18: l (n  -- 9) 14.0 7.3 
18:2( n -- 6) 4.9 3.4 
20:4(n - 6) lc).4 7.1 
22:4(n - 6) 0.9 0.4 
22:5(n- 3) 1.3 0.6 
22:6(n - 3) 6.5 22.6 
a Only fatty acids found at greater than 0.5% are shown. 
crease if mice were fed a fish oil-containing ((n - 3) fatty 
acid-rich) diet. In our experiments, weanling BALB/c 
male mice were fed diets containing essential fatty acids 
and 10% additional fat as some ratio of HCO and MO, or 
as CO. After 3 weeks on the diets, the spleens were 
removed, and single cell suspensions were stained with 
phycoerythrin-labeled anti-Thy-l.2 and analyzed by flow 
cytometry to produce the histograms shown in Fig. 3. 
Histogram similarity was assessed by linear regression 
using the program Regress ® (Boehringer-Mannheim, Indi- 
anapolis, IN) [16]. Histograms generated using anti-Thy- 
1.2-stained cells from mice on different diets were overlaid 
and the number of cells per fluorescence intensity treated 
as paired data. For similar diets, there would be no differ- 
ence in the resultant histograms, and the paired data would 
yield a significant correlation with a slope of 1.00 (line of 
identity). As histograms become less similar, the paired 
data would begin to deviate from the line of identity. This 
deviation per data point represents he residual values. The 
mean residual is expressed as a percentage of the control 
histogram peak height (because the units are cell numbers 
rather than fluorescence intensities) to yield a regression 
index (RI). Fig. 3A shows regression analysis that resulted 
in similar histograms; these were histograms of Thy-1 
expression on splenocytes from mice fed corn oil and 
hydrogenated coconut oil-rich diets. The paired data show 
a good correlation about the line of identity with a resul- 
tant RI of 8.11. Fig. 3B demonstrates visibly dissimilar 
histograms, data from corn oil and menhaden oil-fed 
groups. The paired data show correlation about a line 
(slope < 1.0) with positive residuals in the first 200 
channels resulting in an RI of 31.50. The regression index 
therefore represents a sensitive index for monitoring rad- 
ual changes in cytometric histograms that may not be 
detected using mean fluorescence intensity alone [16]. 
The data in Fig. 3, a representative experiment of the 
three performed, demonstrate hat sptenocytes from satu- 
rated fat (HCO)-fed mice displayed Thy-1 expression 
equivalent o CO-fed (control) mice, whereas MO-fed 
splenocytes howed a decrease in the percentage of 
brightly-staining cells and an increase in the percentage of
negative cells. It was not clear whether the alteration was 
the result of brightly staining cells becoming negative, or a 
general decrease in Thy-1 expression in which the bright 
cells became dull, and the dull cells became negative. In 
either case, however, this analysis is consistent with the 
results of the complement-mediated lysis assay. Propidium 
iodide staining was also done to ensure viability, and the 
six diet groups were more than 98% viable. The histogram 
for diet 1 (10.5% CO) was overlaid sequentially with those 
of the other five diets to generate RI values. The greater 
the RI value, the more disparate the two histograms. As 
shown in Fig. 4, the RI increased as the percentage of MO 
in the diet (diet number) increased. This suggested that the 
apparent loss of Thy-1 bright cells from the spleen was 
associated with the presence of MO in the diet. Gas 
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Fig. 4. Increased ietary MO correlated with decreased Thy-1 expression. 
Weanling mice were fed various amounts of CO, HCO, and MO (diets 1 
to 6) for 3 weeks. Splenocytes from three mice on identical diets were 
pooled, stained with phycoerthrin-conjugated anti-Thy-l.2, and analyzed 
by flow cytometry. Histograms from diets 2 through 6 were overlaid with 
the histogram from diet 1, and regression indices (RI) were calculated. 
The greater the RI value, the more Thy-1 expression deviates from diet 1. 
The solid line is a first order linear regression; the dotted lines are 95% 
confidence limits. There is a significant correlation between dietary MO 
and Thy-1 expression, i.e., RI (P  = 0.0366, Pearson product moment 
correlation). 
chromatography revealed an increase in DHA in spleno- 
cytes from MO-fed mice (Table 5). 
Although the physiological conditions created by the 
MO diet may have fostered the migration of Thy-1 bright 
cells away from the spleen (or the migration of Thy-I dull 
cells to the spleen), the experiments performed in vitro rule 
out selective migration as the sole mechanism for dietary 
fish oil's effect. To confirm that the two assays (flow 
Table 5 
Fatty acid composition of spleen cells from mice fed experimental diets 
Fatty acid % of total fatty acids a 
Diet: 1 2 3 4 6 
14:0,14:1 1.9 3.1 2.3 2.8 2.2 
16:0 28.3 27.9 19.3 25.9 26. l 
18:0 18.2 12.7 11.9 13.3 14.2 
18:l(n -9 )  21.3 23.9 17.0 19.4 18.3 
18:2(n -6 )  15.5 5.0 7.0 7.8 6.6 
18:3(n -3 )  - 6.3 1.8 tr 2.2 
20:4(n - 6) 4.4 8.2 2.1 3.5 3.6 
20:5(n -3 )  - - 3.2 4.8 5.3 
22:4(n - 6) 5.7 3.9 1.7 - 0.7 
22:5(n - 3) - - 1.2 2.6 2.4 
22:6(n - 3) b -- -- 2.7 5.8 6.3 
a tr, trace; --, not detectable. 
b Correlation between % dietary MO and % DHA, P = 0.0238 
product moment correlation). 
(Pearson 
Table 6 
Thy-I expression on splenocytes modified by fusion with 18:0,22:6 PC 
Lipid concentration Relative Thy- 1 DHA content (% of 
(mg/ml)  expression (RI) total fatty acids) 
0 0 0.2 
0.25 10.55 1.4 
0.5 12.08 0.7 
1.0 15.17 2.1 
cytometry and specific lysis) measured parallel events, we 
fused splenocytes with various amounts of 18:0,22:6 PC, 
stained them with phycoerythrin-conjugated nti-Thy-l.2, 
and analyzed them with the flow cytometer. As shown in 
Table 6, supplementation f splenocytes with 18:0,22:6 PC 
produced high RI values, and inspection of the histograms 
(not shown) revealed that the Thy-I bright population was 
reduced in the 18:0,22:6 PC-treated groups. Reduced Thy-1 
expression was most striking with unfixed cells, but also 
found in two additional experiments in which the cells 
were fixed prior to flow cytometry. The fused unfixed cells 
had greater than 95% viability as shown by propidium 
iodide staining. Gas chromatography revealed a modest 
increase in DHA due to the fusion of 18:0,22:6 PC with 
the splenocyte membrane. Thus, in a static lymphocyte 
population, immediately after the addition of DHA to the 
plasma membrane, the binding of anti-Thy-1.2 to the cells 
was reduced. This finding is consistent with the hypothesis 
that membrane-bound DHA alters some aspect of mem- 
brane protein structure. 
3.2. Effect of DHA on CD8 expression 
Thy-1 is implicated in T cell activation; however, dur- 
ing an immune response T cells are activated by recogni- 
tion of foreign antigen. CD8 plays an accessory role in T 
activation by antigen, and thus is an interesting model for 
further study of DHA's effect on immunologic surface 
molecules. We supplemented spleen cells with DHA either 
by fusion with 18:0,22:6 PC or by culture in fatty acid- 
supplemented medium (plus Con A). We then used a panel 
of monoclonal antibodies against CD8 in the complement- 
mediated lysis assay to monitor CD8 expression. 
As shown in Fig. 5 (one of four experiments), different 
epitopes on CD8 (a  chain) were modulated by 18:0,22:6 
PC. The epitopes bound by monoclonal antibodies HO-2.2 
and 3.155 demonstrated a significant increase in expres- 
sion, whereas the epitope detected by monoclonal antibody 
2.43 showed a significant decrease. Besides indicating that 
CD8, as well as Thy-l, is sensitive to the membrane 
alterations associated with DHA, these results also empha- 
size that DHA's effect is more than a nonspecific decrease 
in antibody binding. 
As before, we extended the experiments to measure 
epitope expression on Con A-stimulated splenocytes cul- 
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Table 7 
Comparison of lipid vesicle fusion and fatty acid-supplemented medium 
for their effects on CD8 expression 
Lymphocyte treatment % of no DHA control; 
CD8 epitope xpression 
HO-2.2 2.43 3.155 
Fusion with 18:0,22:6 PC 215 13 132 
Culture in DHA 181 50 112 
of biosynthetic ncorporation of DHA on CD8 expression 
match the effects of 18:0,22:6 PC (Table 7), both qualita- 
tively and quantitatively. 
AMOUNT OF  18:0 ,22:6  PC IN L IP ID  SUSPENSION (mg/ml)  
Fig. 5. Fusion of 18:0, 22:6 PC with splenocytes alters expression of three 
CD8 epitopes. 51Cr-labeled splenic blasts were fused with various amounts 
of 18:0, 22:6 PC, and then treated with monoclonal anti-CD8 (HO-2.2, 
2.43, and 3.155) plus complei~nent. The data shown are means 4- S.D. 
(n = 3). 
tured in fatty acid-supplemented media. Fig. 6 shows that 
the incorporation of DHA into splenocytes increased bind- 
ing of the HO-2.2 antibody and decreased the binding of 
the 2.43 antibody. In this experiment, the increase in 3.155 
binding to DHA-supplernented cells did not reach statisti- 
cal significance at the 95.% confidence level (P  = 0.0695, 
Student's t-test), although small but significant increases 
were found in other experiments. Importantly, the effects 
3.3. Persistence of the .fish oil diet effect 
(n -  3) fatty acids are preferentially retained in some 
cell types even after removal from the diet [1]. To test 
whether the influence of MO diet on Thy-1 expression 
persisted after removal of MO from the diet, we performed 
the following experiment. Mice were fed a diet containing 
10% MO or 10% HCO for 3 weeks, and then half of the 
mice on the MO-containing diet were switched to a diet 
with 10% HCO. Periodically thereafter, lymphocytes were 
stained with anti-Thy-l.2, and the flow cytometry data 
were analyzed with the Regress ® program. Nine days after 
the diet switch, comparison of MO-fed and diet-switched 
splenocytes produced an RI of 5.7, considerably lower 
than the RIs for comparison of MO and HCO-fed cells 
(RI = 19.5), and HCO-fed and diet-switched cells (RI = 
30, 
25 
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o 
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09 
o~ lO 
H0-2 .2  2.43 .k 3.155 ** 
NONE 22:6 NONE 22:6 NONE 22:6 
FATTY ACID SUPPLEMENT IN CULTURE MEDIUM 
Fig. 6. Splenocyte culture in DHA-supplemented medium alters CD8 expression. Splenocytes were cultured in medium plus 5% FBS and ~ 25 /.tg/ml of 
BSA-bound 22:6 for 2 days in the presence of Con A. Splenic blasts were 5n Cr-labeled, and treated with rnonoclonal anti-CD8 (HO-2.2, 2.43, and 3.155) 
plus complement. The data shown are means 4- S.D. (n = 3). One asterisk denotes ignificant difference from control (P  < 0.05, Student's t-test); two 
asterisks denotes P = 0.0695. 
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20.6). This suggests that after 9 days on the HCO diet, 
splenocytes retained the phenotype characteristic of the 
MO diet. Tests made at later times, 21 and 35 days after 
switching the diets, produced high RIs (14 to 42) for the 
various comparisons. Thus, there was some retention of 
the diet-induced effect on Thy-I expression, although in 
this experiment a long-lasting effect was not demonstrated. 
4. Discussion 
In this paper we demonstrate hat the presence of DHA 
in lymphocyte plasma membranes i associated with de- 
creased expression of Thy-1 (the epitope defined by mono- 
clonal antibody from clone 30-H12) and altered expression 
of three CD8 epitopes (defined by monoclonal antibodies 
HO-2.2, 2.43, and 3.155). DHA was incorporated into 
membranes through diet (dietary fish oil), fatty acid-supp- 
lemented culture medium, and fusion with lipid vesicles of 
18:0,22:6 PC. Although diet and cell culture may change 
cellular constituents other than the DHA content of mem- 
brane phospholipids, fusion occurs rapidly without oppor- 
tunity for substantial metabolic hanges. Additionally, al- 
though DHA may be incorporated into internal membranes 
through diet or culture, 18:0, 22:6 PC incubation with 
lymphocytes for a brief period in the cold is most likely to 
place DHA in the plasma membrane. Therefore, it is our 
opinion that the effect of DHA is related to its structural 
role in plasma membranes. Because both Thy-1 and CD8 
are implicated in T cell activation, the changes in mem- 
brane lipid bilayer structure that influence protein structure 
(i.e., epitope expression) may influence Thy-I and CD8 
function during cell activation. 
Earlier reports have provided evidence that Thy-1 is 
sensitive to the lipid components of the plasma membrane. 
Muller et al. [25] reported that splenocyte treatment with a 
phosphatidylcholine preparation ('active lipid') not only 
decreased lipid packing (as probed with DPH) but also 
reduced Thy-I expression (as monitored by flow cytome- 
try with anti-Thy-l.2, clone 30-H12). We have found a 
similar relationship between packing of 18:0, 22:6 PC 
(deduced from pressure/area isotherms) [9] and reduced 
Thy-1 expression (this paper), which is consistent with the 
work of Muller and coworkers. Muller et al. [25] also 
observed that cholesteryl hemisuccinate did not alter Thy-1 
expression, although MHC I expression was reduced by 
cholesterol treatment. However, Traill and Wick [26] did 
describe work by these investigators in which cholesterol 
affected Thy-1 expression on the T cell lymphoma EL4. 
Twisk et al. [27] found by flow cytometry that lympho- 
cytes from mice fed a 5% lard diet (containing principally 
18:1, 16:0 and 18:0) had greater Thy-1 expression com- 
pared to a 5% sunflower diet (principally 18:2 and 18:1). 
Yet, in an earlier report, Twisk et al. [28] found no effect 
of culture in 18:2, 18:3, 20:4 or 20:0 on lymphocyte Thy-1 
expression. Thus, Thy-1 expression is sensitive to mem- 
brane lipid composition, but the relationship between Thy- 1 
expression and membrane structure is complicated and 
poorly understood. 
CD8 is less well studied with respect o fatty acid or 
lipid modulation of expression. Fernandes [7] reported 
increased CD8 expression on splenocytes from mice fed 
20% fish oil compared to those fed 20% lard or corn oil; 
calorie restriction, associated with enhanced longevity, 
similarly increased the percentage of CD8 + splenocytes. 
Othet al. [8], in contrast, found no difference in CD8 (or 
Thy-l.1) expression on T cell lymphoma cells grown in 
fish oil and beef tallow-fed mice, whereas the fish oil diet 
was associated with lower CD4 expression. Direct compar- 
ison should be made carefully, however, because there are 
substantial differences between these two studies, and our 
study as well: cell type, monoclonal antibody clone, mouse 
strain (autoimmune-prone, l ukemia-prone, and normal), 
oil sources (although the fatty acid compositions were 
comparable for the three fish oils, and for the three satu- 
rated fats), final fat content of the diets, and pre-existing 
DHA in membranes. 
It is not clear what membrane change is reducing the 
binding of Thy-1 and CD8 to the monoclonal antibodies. 
There are three nonexclusive mechanisms by which DHA, 
esterified to membrane phospholipids, may affect mem- 
brane protein expression. These three mechanisms are 
conformational change, vertical displacement, and qualita- 
tive changes in neighboring proteins, all of which may 
result from DHA-induced membrane domain formation. 
The latter two mechanisms also incorporate the idea of 
epitope masking, i.e., neighboring proteins reducing acces- 
sibility of Thy-1 or CD8 epitopes to the antibody probes. 
The underlying hypothesis is that DHA promotes the 
formation of membrane microdomains, those that are rich 
in DHA and poor in cholesterol, and those that are DHA- 
poor and cholesterol-rich. Cholesterol does not interact 
well with DHA, and thus is thought o be preferentially 
excluded from DHA-rich domains [9]. Because both DHA 
(as we have shown here) and cholesterol [26] influence 
Thy-I expression, we predict that formation of DHA- 
rich/cholesterol-poor and DHA-poor/cholesterol-rich do-
mains (by addition of DHA or cholesterol) will impel 
Thy-1 and CD8 to segregate into domains having their 
favored lipid environments. Segregation i to domains may 
alter protein expression without necessitating a change in 
biosynthesis. Fatty acids are components of the annular 
lipids surrounding membrane proteins, and therefore DHA 
may affect protein conformation through this interaction. 
Additionally, because of its six double bonds, DHA is 
proposed to assume a helical structure and produce a 
bilayer that is thinner than saturated bilayers [29]. From the 
protein's perspective, this may change its position relative 
to other membrane components and the external milieu 
(e.g., antibodies). Furthermore, Thy-1 is GPI-linked, and 
DHA may be esterified to Thy-l's lipid anchor. Although 
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DHA is not prominent among fatty acid founds in PI, the 
DHA content of PI can be enriched through diet or cell 
culture [30,31]. The ac~l chain composition of Thy-I is 
reportedly variable [32], containing, in addition to stearic 
acid (18:0), alleged C20 and C22 fatty acids [33]. Thus, it 
is certainly of interest to test whether DHA may be 
covalently attached to Thy-1. 
DHA-induced microdomains may also harbor a qualita- 
tively or quantitatively different assortment of proteins, 
providing Thy-I and CD8 with new neighbors that may 
mask epitopes, affect protein-protein teractions, and in- 
fluence protein function In the T cell plasma membrane, 
Thy-1 associates with another GPI-l inked protein, Ly-6, in 
a large complex that also includes tyrosine kinases (p56 rck, 
p60 fyn, p53/p56 tyn) [34,35]; presumably the proximity of 
these molecules will affect the probability of their collid- 
ing and forming a complex. Because Thy-1 appears to 
diffuse in a domain 1 to 2 /xm wide [36], and other 
GPI-l inked proteins have a similar barrier-free path [37], 
one expects that the two molecules, Thy-1 and Ly-6, may 
hunt for each other and for kinases prior to complex 
formation. On the other hand, if Thy- 1 naturally clusters in 
a microdomain of a given lipid composition, then it is 
likely to closely interact with those proteins gathered into 
the same domain. There is evidence to support lipid-in- 
duced clustering of GPI-l inked proteins into membrane 
patches [38]. The testable hypothesis is that Thy-1 and 
Ly-6 prefer the same lipid environment. 
Like Thy-1, CD8 associates with molecules on the cell 
surface, the T cell antigen receptor and a tyrosine kinase 
[15], and thus may chtster with its protein partners in 
microdomains. Structural changes induced by DHA may 
potentiate or curb cell activation, i.e., group or separate 
molecules. Although potentiation would, theoretically, 
heighten a T cell response, it may be equally advantageous 
to increase the threshold required for T cell activation to 
decrease the chance of autoimmunity. Clearly, (n -3 )  
fatty acids have hormonal effects that moderate autoim- 
mune inflammation. However, in addition, the correlation 
between dietary (n - 3) fatty acids and reduced severity of 
autoimmune disease is consistent with DHA-induced mem- 
brane alterations that modulate T cell activation. It is now 
important to explore the relationship between DHA-in- 
duced changes in Thy-1 (and CD8) expression and cellular 
activation. 
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